Drug Profile
mRNA 1325
Alternative Names: mRNA-1325; Zika mRNA vaccine- Moderna TherapeuticsLatest Information Update: 18 Jul 2019
Price :
$50
*
At a glance
- Originator Moderna Therapeutics
- Class RNA; RNA vaccines; Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Zika virus infection
Most Recent Events
- 01 Jul 2019 Moderna completes a phase I trial in Zika virus infection (Prevention) in USA (Parenteral) (NCT03014089)
- 06 Mar 2019 Discontinued - Phase-I for Zika virus infection (Prevention) in USA (IM)
- 11 Jul 2018 Moderna completes enrolment in its phase I clinical trials in Zika virus infection (Prevention) in USA (Parenteral) (NCT03014089)